Table 4.
Comparison of metabolic prognostic and inflammatory parameters between pre- (T0) and post-intervention (T1).
| T0 | T1 | Statistics | |||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | p-Value | ES | %Δ | |
| Glycemia (mg/dL) | 100.8 ± 11.4 | 91.7 ± 11.0 | <0.001 | 1.15 | −9.1% |
| Insulin (microU/mL) | 7.92 ± 4.68 | 6.49 ± 3.94 | 0.018 | 0.47 | −18.1% |
| HOMA Index | 2.07 ± 1.54 | 1.53 ± 1.11 | 0.005 | 0.57 | −26.1% |
| Triglycerides (mg/dL) | 102.8 ± 43.7 | 93.3 ± 43.7 | 0.091 | 0.32 | −9.3% |
| HDL (mg/dL) | 62.3 ± 15.9 | 60.8 ± 13.5 | 0.242 | 0.22 | −2.5% |
| LDL (mg/dL) | 137.7 ± 29.9 | 126.1 ± 28.3 | <0.001 | 0.77 | −8.4% |
| Total cholesterol (mg/dL) | 217.7 ± 39.3 | 208.5 ± 37.3 | 0.029 | 0.43 | −4.3% |
| Progesterone (ng/mL) | 0.52 ± 0.40 | 0.50 ± 0.21 | 0.750 | 0.06 | −4.0% |
| Testosterone (ng/mL) | 0.34 ± 0.27 | 0.24 ± 0.20 | 0.003 | 0.60 | −28.9% |
| hs-CRP (mg/L) | 2.18 ± 2.14 | 1.75 ± 1.74 | 0.027 | 0.43 | −19.9% |
| hs-Troponin (ng/L) | 3.07 ± 1.14 | 2.73 ± 2.72 | 0.479 | 0.13 | −11.0% |
Abbreviations: ES, Cohen’s d effect size; %Δ, percentage changes over time; HOMA, homeostasis model assessment; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs, high sensitive; CRP, c-reactive protein.